Nanosynex
Company

Last deal

$83.3K
Local Amount - EUR 71.4K

Amount

Grant

Stage

01.06.2018

Date

2

all rounds

$83.3K

Total amount

General

About Company
NanoSynex develops diagnostic tests that check bacterial resistance to antibiotics.

Industry

Sector :

Subsector :

founded date

09.02.2017

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's tests use a phenotypic approach and microfluidic disposable test cartridges to optimize bacterial growth and provide same-day results. This helps reduce the spread of resistant bacteria in the environment and lower healthcare costs by limiting prolonged hospitalization. The technology is based on a revolutionary scientific development from the Technion.
Contacts

Social url